Skip to main content
ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
3.480
-0.200 (-5.43%)
At close: Jul 2, 2024, 4:00 PM
3.460
-0.020 (-0.57%)
After-hours: Jul 2, 2024, 7:24 PM EDT

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $68.62M in the twelve months ending March 31, 2024, down -62.38% year-over-year. Revenue in the quarter ending March 31, 2024 was $18.05M, a -4.94% decrease year-over-year. In the year 2023, ADC Therapeutics had annual revenue of $69.56M, a decrease of -66.86%.

Revenue (ttm)
$68.62M
Revenue Growth
-62.38%
P/S Ratio
4.88
Revenue / Employee
$251,352
Employees
273
Market Cap
334.87M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 20200--
Dec 31, 20192.34M1.20M105.26%
Dec 31, 20181.14M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacific Biosciences of California 200.43M
AxoGen 163.73M
Sight Sciences 81.50M
Foghorn Therapeutics 33.90M
C4 Therapeutics 20.04M
Verrica Pharmaceuticals 8.91M
Absci 5.35M
Revenue Rankings

ADCT News

More News